Latest news
Natera Submits Signatera™ to Japan’s PMDA for Approval as a Companion Diagnostic in Muscle-Invasive Bladder Cancer - BioSpaceBioSpace · Thu, 06 Aug 2026 03:07:25 GMTInternational Bladder Cancer Group recommends integrating actionable biomarkers into bladder cancer care - Bioengineer.orgBioengineer.org · Wed, 05 Aug 2026 22:48:47 GMTYou’re Invited to a Bladder Cancer Patient Experience Discussion on May 14 - UroTodayUroToday · Tue, 28 Jul 2026 14:09:05 GMT